# Scientific decision — second initial-phase trial



Only the two within-component copula correlations change. The first isolated trial (seed 6101, 3000 rows) had E1=.053155, E2=.425588 and E3=.008369, with Pearson .647685 and Spearman .432592. All thirty diagnostics were computed; no nonpositive glycemia or duplicate measurement rows were reported. Interval membership is not equivalence.



The rank excess over .361457 is large enough to motivate a limited structural check. Core rho changes .40 to .28; broader rho is 0.5871524663503118 after deterministic covariance re-solving, preserving intended population E2/Pearson under the scaffold. These are fitted developmental choices, not new clinical evidence. The calculation generates no random draws or cohort tables.



Margins and covariate shifts are retained. Glucose SD 1.4411 (reference 1.5445) and q90 6.331 (reference 6.579) may combine tail sampling with the known approximate CDF fit; one realization does not identify the cause. We therefore do not rescale the model to compensate this seed. Age, female, BMI and HbA1c results are retained as delivered feedback, not selectively discarded.



Please run one new 3000-row table through the isolated session at the coordinator-prescribed second trial seed. This consumes the last initial-phase trial slot. No local generator execution has occurred. No new retrieval (0 queries/0 downloads), and no external source replay.



The following first-trial scientific rationale remains applicable except for the superseded .40 core correlation and first-trial request:



# Scientific decision â€” first numerical trial requested



This is one fresh reference-assisted construction for the selected CHNS 2009 ages 35â€“74 complete-case analytical population. Every row and all five clinical variables are synthetic. The supplied CHNS aggregate reference is deliberately used for fitting; its sample estimates and cluster-based coefficient intervals are not population truth. Agreement is development-reference fit, not new validation.



I chose a two-component bounded lognormal mixture for glucose and HbA1c. A narrow central component plus a broader component lets rare large departures affect Pearson covariance more than ranks, addressing the reference Pearson 0.661 versus Spearman 0.361. Component membership is an unidentified distributional device, not observed diabetes, treatment, pregnancy or a clinical label. Within each component a Gaussian copula connects the two biomarkers. The component probability and four marginal parameters per biomarker were fitted to the reference means, individual SDs and three quantiles using deterministic moments and CDF integration; no synthetic rows or random integration draws were generated. The first core copula correlation 0.40 is an explicit assumption, and the broader-component correlation was solved by deterministic quadrature to supply the desired baseline covariance. Spearman fit remains untested.



Age has a maximum-entropy discrete distribution on the declared support; means/variance and chosen CDF constraints within the three observed quantile bins determine its probabilities. BMI is a nearly untruncated lognormal matching its mean/SD. Female is Bernoulli at the reference fraction. Independence of age, female and BMI, and female's absence from biomarker equations, are simplifying unidentified assumptions, not conclusions from absent reported associations. This construction does not support inference about sex differences or those unreported covariate associations.



Small additive age and BMI terms preserve the three requested regression interpretations. BMI's coefficient is directly fitted to E1. With age/BMI independent of the latent mixture, the baseline glucoseâ€“HbA1c covariance and a glucose age shift jointly yield E2, and the HbA1c age shift minus E2 times the glucose age shift yields E3. This is an algebraic moment construction, not a causal structural model. Dependence neglected by the scaffold remains an uncertainty even when these three projections agree.



All actual scientific numerical targets come from `CHNS_DEV_REF`. The admitted external audit is contextual: Bao reports an unadjusted plasma Pearson coefficient; MIND reports a serum Spearman coefficient with older/rural selection and imputation; Jansen reports distinct age/gender adjusted projections under diabetes/anemia exclusion and IFCC units; Pani reports a weighted NHANES age slope with named task-like adjustment but different disease selection and plasma measurements. Jansen age information restored in the full audit is recognized. None is silently pooled or equated to the CHNS parameters. NGSP is unit context, not a glucose model. No source replay or new original-study retrieval was performed; query/download counts are 0/0.



The baseline biomarker distributions have finite upper/lower support; age and BMI are bounded. Even after the largest negative additive shifts, glucose exceeds 2.2 mmol/L and HbA1c exceeds 2.4%; all moments are finite. Bounds (BMI 10â€“55, baseline glucose 2.5â€“25 and HbA1c 3.5â€“16) are explicit working assumptions, not observed reference extrema. Measurement rounding to 0.01 mmol/L glucose and 0.1% HbA1c is a declared approximation; it is not a verified instrument resolution. The mixture tail shape, bounds, heteroscedasticity and subgroup behavior are not identified by the aggregates.



`analytic_fit.json` records deterministic calculations, not executed generator performance. Please execute ONE first 3000-row numerical trial through the supplied isolated session and return all 30 statistics. No generator has been run locally. Row count is a design/budget choice. The next scientific decision will distinguish finite-sample fluctuation from a recurrent structural discrepancy; no favorable-seed selection or desired p-value fitting is authorized. Generated sample precision does not include evidence, transport or structural uncertainty.



## Calculation artifact retention



The marginal optimizer was retained when run. The covariance solver initially ran inline and was retained afterward in covariance_solver.py from the executed calculation. Its first unclipped inverse-normal calculation failed root bracketing; adding finite probability clipping corrected the deterministic numerical issue before ar01 submission. This failed mathematical calculation produced no cohort and consumed no numerical table slot. The retained solver reproduces either core-correlation setting without sampling or generator execution. The current analytic_fit.json combines marginal results with the subsequent covariance calculation; both scripts are now hash-bound.

